Teva appoints former Modern CMO Tal Sachs as board of directors


0

Steering committee Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: YOUR) appointed by dr. Tal Zaksa for board member. The appointment takes effect on October 1, 2021, until the next annual general meeting of shareholders in 2022.

Zaks resigns as chief physician of the development engineer and vaccine manufacturer Moderna Inc. (Nasdaq: MRNA) after six years spent in that position and will continue to serve as a special adviser to the CEO of Moderna until the end of September. Zak’s salary on the board of directors of Teva will be identical to the salaries of other independent directors on the board of the Israeli pharmaceutical company, as announced to the American SEC on April 20, 2020.

Teva’s management has decided that Zacks is capable of working on the board as an independent director according to the registration rules submitted on the New York Stock Exchange. He has also been appointed to the Science and Technology Committee, and could be appointed to additional committees in the future. Sachs graduated from Ben Gurion University in the Negev.

Posted by Globes, Israeli Business News – en.globes.co.il – August 27, 2021

Copyright by Globes Itonut (1983) Ltd. 2021


Like it? Share with your friends!

0

What's Your Reaction?

hate hate
0
hate
confused confused
0
confused
fail fail
0
fail
fun fun
0
fun
geeky geeky
0
geeky
love love
0
love
lol lol
0
lol
omg omg
0
omg
win win
0
win
Stacy

0 Comments

Your email address will not be published. Required fields are marked *